|
|
| |
 |
| |
Targeting cancer stem cells
could be a powerful way to beat cancer in the future (Image from
the Cancer Research UK LRI EM Unit) |
| |
What did they do?
It’s very difficult to work with ‘real life’ cancer stem cells, as
they only make up a tiny fraction of cells in a given tumour, so
are tricky to extract from tumour samples. |
| |
So the researchers developed a technique for
growing immortal – but non-cancerous – human breast cells in the
lab, and then used genetic engineering to give them the properties
of cancer stem cells. This meant that they could grow stem
cell-like cancer cells in thousands of tiny plastic
dishes. |
| |
The next step was to expose these cells to
thousands of different chemical compounds, to find ones that killed
them. To start with, the scientists studied around 16,000
compounds, including those from commercial chemical ‘libraries’ as
well as extracts from natural sources. Just 32 of these killed the
stem cell-like cells. And, of these, only four worked
consistently. |
| |
Narrowing it down further, the researchers found
that one chemical – an agricultural antibiotic called salinomycin –
was particularly selective and effective at killing off the stem
cells. Further tests in the lab showed that salinomycin was
over a hundred-fold more effective at killing cancer stem cells
than paclitaxel – a commonly-used
breast cancer drug. |
| |
Tests with mice transplanted with human breast
cancer cells revealed that salinomycin was effective at reducing
the levels of stem cells in the tumours, and reduced the chances of
the cancer spreading around the body. |
| |
Is salinomycin the ‘cure for
cancer’?
We need to stress that these were laboratory experiments, and there
is no evidence yet that salinomycin can treat cancer in
humans. Salinomycin is currently used as an antibiotic for
chickens and cows, and it can be toxic
or even fatal to humans, causing serious muscle and heart
problems. |
| |
There’s still a long way to go before salinomycin
is tested in cancer patients, and we would not recommend anybody to
take salinomycin as a treatment for cancer. More research
needs to be done to find out if it works on human tumours in the
body, and if a safe dose can be given. |
| |
It may even be the case that salinomycin itself
never makes it to the clinic. Quite often researchers need to tweak
the chemical formula of a promising compound to make it safe or
effective, and this can take time. Or there are serious side
effects that mean that it’s unsafe for general
use. |
| |
What
are cancer stem cells?
We’ve got a longer
post here explaining more about cancer stem cells, and
research into them. Briefly, cancer stem cells are
rare ‘immortal’ cells that are found in a number of different
cancers, including breast, bowel and prostate cancer, and
leukaemia. They produce not only ‘normal’ cancer cells
that go on to divide many times, forming the bulk of the tumour
– but also make new cancer stem cells.
Although they’re
elusive, many researchers think cancer stem cells are the driving
force behind many cancers. Certainly, they’re resistant to
radiotherapy and chemotherapy. The theory goes that these
treatments kill off the ‘normal’ tumour cells but don’t touch the
stem cells. Eventually these start growing again and the cancer
comes back.
Although the
importance – and in some cases existence – of cancer
stem cells is still a hotly-debated topic in research, there is a
growing body of evidence to suggest that rogue stem cells may play
a role in at least a proportion of cancers.
Many researchers
around the world – including several funded by
Cancer Research UK – are working on the challenge of cancer
stem cells. And now Piyush Gupta and his colleagues in the
States have made an important scientific breakthrough, throwing
the door open to exciting future treatments for
cancer. |